Long-term Gene Silencing in Mammalian Cells using siRNA
Poster Feb 01, 2007
Frank Narz, Silke Janhsen and Martin Weber
Gene silencing using siRNA-mediated RNAi has become a powerful tool in cell biology, addressing a range of research questions in functional genomics and drug discovery. After delivery of siRNA into the cell, rapid degradation of the target mRNA can be detected, often within 24 hours, and subsequently the corresponding protein is also knocked down.
This knockdown is transient, especially when working with proliferating cell lines where the intracellular siRNA is diluted with each cell division. As most cell lines have to be subcultured approximately twice a week, siRNA-mediated RNAi experiments are usually analyzed 3–4 days after transfection. In many cases, this short-term knockdown is too brief and phenotypic effects that require a longer duration of knockdown of the target protein cannot be examined.
We have developed a protocol that allows gene silencing in mammalian cells for more than 2 weeks. siRNA is transfected using lipid-based HiPerFect Transfection Reagent every time the cells are diluted and plated into a new culture plate.
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019